Info

Cytokinetics, Incorporated (Cytokinetics) is a biopharmaceutical company focused on developing small molecule therapeutics for the treatment of cardiovascular diseases and cancer. The Company’s development efforts are directed to advancing multiple drug candidates through clinical trials to demonstrate proof-of-concept in humans in two markets: heart failure and cancer. Cytokinetics’ drug development pipeline consists of a drug candidate for the treatment of heart failure, being developed in both an intravenous and oral formulation, and two drug candidates and a potential drug candidate for the treatment of cancer. Its drug candidates and potential drug candidates are all novel small molecules that arose from its internal research programs and are directed toward the biology of the cytoskeleton.(Source: 10-K)